Twist Bioscience Files Q2 2025 10-Q
Ticker: TWST · Form: 10-Q · Filed: May 5, 2025 · CIK: 1581280
| Field | Detail |
|---|---|
| Company | Twist Bioscience Corp (TWST) |
| Form Type | 10-Q |
| Filed Date | May 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, earnings, biotech
TL;DR
Twist Bioscience dropped its Q2 2025 10-Q. Check financials.
AI Summary
Twist Bioscience Corp. filed its 10-Q for the period ending March 31, 2025. The filing covers the second quarter of their fiscal year. Key financial data and business operations for this period are detailed within the report.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for Twist Bioscience, crucial for understanding the company's trajectory in the synthetic biology market.
Risk Assessment
Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial health and market position of Twist Bioscience would determine the actual risk.
Key Players & Entities
- Twist Bioscience Corp. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250505 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date (FILED AS OF DATE) is 20250505.
What is Twist Bioscience Corp.'s Standard Industrial Classification (SIC) code?
Twist Bioscience Corp.'s SIC code is 2836, categorized under BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What is the fiscal year end for Twist Bioscience Corp.?
Twist Bioscience Corp.'s fiscal year ends on 0930.
What is the SEC file number for Twist Bioscience Corp.?
The SEC file number is 001-38720.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 5, 2025 regarding Twist Bioscience Corp (TWST).